Advertisement

Future Directions

  • Shabir Ahmad Ganai
Chapter

Abstract

HDACi have shown promising results against a myriad of neurological disorders including AD, HD, PD, SMA, ALS and epilepsy. It is quite evident that in a particular neurological complication, neuronal death or damage is not general, but specific brain regions are particularly affected. Different focal pathologies are exhibited by distinct disorders, and thus gaining insights regarding the region-specific effects of these inhibitors is requisite for targetting correct brain areas. This will subsequently mitigate the toxicity in the normal brain regions.

References

  1. Agis-Balboa RC, Pavelka Z, Kerimoglu C, Fischer A (2013) Loss of HDAC5 impairs memory function: implications for Alzheimer’s disease. J Alzheimers Dis 33(1):35–44CrossRefGoogle Scholar
  2. Basso M, Chen HH, Tripathy D, Conte M, Apperley KYP, De Simone A, Keillor JW, Ratan R, Nebbioso A, Sarno F, Altucci L, Milelli A (2018) Designing dual transglutaminase 2/histone deacetylase inhibitors effective at halting neuronal death. ChemMedChem 13(3):227–230CrossRefGoogle Scholar
  3. Ganai SA (2016) Panobinostat: the small molecule Metalloenzyme inhibitor with marvelous anticancer activity. Curr Top Med Chem 16(4):427–434CrossRefGoogle Scholar
  4. Ganai SA (2017) Small-molecule modulation of HDAC6 activity: the propitious therapeutic strategy to vanquish neurodegenerative disorders. Curr Med Chem 24(37):4104–4120PubMedGoogle Scholar
  5. Gantt SL, Gattis SG, Fierke CA (2006) Catalytic activity and inhibition of human histone deacetylase 8 is dependent on the identity of the active site metal ion. Biochemistry 45(19):6170–6178CrossRefGoogle Scholar
  6. Guan J-S, Haggarty SJ, Giacometti E, Dannenberg J-H, Joseph N, Gao J, Nieland TJF, Zhou Y, Wang X, Mazitschek R, Bradner JE, DePinho RA, Jaenisch R, Tsai L-H (2009) HDAC2 negatively regulates memory formation and synaptic plasticity. Nature 459(7243):55–60CrossRefGoogle Scholar
  7. Lobera M, Madauss KP, Pohlhaus DT, Wright QG, Trocha M, Schmidt DR, Baloglu E, Trump RP, Head MS, Hofmann GA, Murray-Thompson M, Schwartz B, Chakravorty S, Wu Z, Mander PK, Kruidenier L, Reid RA, Burkhart W, Turunen BJ, Rong JX, Wagner C, Moyer MB, Wells C, Hong X, Moore JT, Williams JD, Soler D, Ghosh S, Nolan MA (2013) Selective class IIa histone deacetylase inhibition via a nonchelating zinc-binding group. Nat Chem Biol 9(5):319–325CrossRefGoogle Scholar

Copyright information

© Springer Nature Singapore Pte Ltd. 2019

Authors and Affiliations

  • Shabir Ahmad Ganai
    • 1
  1. 1.Division of Basic Sciences and Humanities, Faculty of AgricultureSKUAST-KashmirWadura SoporeIndia

Personalised recommendations